Related Experiment Video
Updated: Oct 9, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C
J M O'Riordan1, A Conroy, C Nourse
1Blood Transfusion Service Board, Dublin, Ireland.
Insights
Neonatal hepatitis C virus (HCV) infection from transfusions before 1991 screening showed 60% anti-HCV and 35% HCV RNA positivity. Most infected infants remained asymptomatic, but some showed mild hepatitis, suggesting lower persistence rates in neonates.
Area of Science:
- Hepatology
- Virology
- Pediatrics
Background:
- Transfusion-transmitted hepatitis C virus (HCV) infection was a significant concern before routine screening.
- Neonatal exposure to HCV through blood transfusions poses unique challenges for understanding transmission and long-term outcomes.
Purpose of the Study:
- To identify infants infected with HCV via transfusions before 1991.
- To determine transmission rates and persistence of transfusion-acquired HCV infection in neonates.
Main Methods:
- A look-back study identified 24 infants transfused between 1980-1991.
- HCV infection status was assessed using anti-HCV antibody and HCV RNA (PCR) testing.
- Donor screening and serological/PCR testing were used to identify infected blood sources.
Main Results:
- Of 20 infants tested, 60% were anti-HCV positive and 35% were HCV RNA positive.
- Among recipients of viraemic blood, 71% were ELISA positive and 41% were PCR positive.
- HCV infection resolved in 42% of cases; most children were asymptomatic, but some had mild hepatitis.
Conclusions:
- Neonatal HCV infection via transfusion can occur, with varying rates of viral clearance.
- Young age at exposure and specific HCV genotypes may influence infection persistence.
- Sharing blood units among multiple infants should be avoided to prevent transmission.
Abstract:
This look-back study was undertaken to identify newborn infants who had been infected with the hepatitis C virus (HCV) as a result of transfusions received before the introduction of routine screening in 1991 and to determine the transmission rates and persistence of transfusion-transmitted HCV infection acquired in the neonatal period. A total of 24 infants, transfused between 1980 and 1991, were identified as having received potentially infected blood from 11 blood donors. Ten of the donors had been administered batches of anti-D in 1977 known to have transmitted HCV genotype 1b infection. HCV RNA was detected in five of these donors when tested in 1994-95; the past donations of five of the donors, who had received anti-D immunoglobulin and had serological evidence of previous HCV infection but who were PCR negative when tested in 1994-95, were considered of lower risk. The source and time of acquisition of HCV infection for the one remaining donor in the study was not determined. Twenty-one (88%) of the 24 children were living at time of lookback. The median age at transfusion was 12 days. The median age at time of testing was 6.3 years. One child, who tested negative, was excluded from further analysis of HCV transmission, due to incomplete transfusion records. Overall, 12 of 20 (60%) children tested were positive for anti-HCV and seven (35%) were HCV RNA positive. Twelve (71%) of the 17 recipients of viraemic blood were ELISA positive and seven (41%) were PCR positive. Resolved HCV infection, as determined by ELISA pos, RIBA pos or indeterminate and PCR negativity, occurred in five of 12 (42%). In many instances there was more than one recipient per HCV infected donation. All of the reported children are clinically asymptomatic. However, the duration of HCV infection is relatively short and there is evidence of a degree of hepatitis in five of the seven children who are HCV RNA positive as judged by mildly elevated transaminase levels. The three who have undergone liver biopsy show mild hepatitis. The lower rates of persistence of HCV infection in this study may be due to the young age at exposure or to the source of infection which for all but one of the children was linked to one HCV genotype from female donors. Sharing of units of blood among multiple infants should be discouraged.
More Related Videos
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

